Featured Suppliers:

Vertex Pharmaceuticals Incorporated

Suppliers

Total : 2 View more »

Vertex Pharmaceuticals Incorporated

Cambridge, MA (Massachusetts) US

Medicines and Medical Drugs, Pharmaceutical Chemical Research and Development Services...

TEL: +617 444 6100 FAX: +617 444 6680
http://www.vrtx.com

Company location:

Vertex Pharmaceuticals Incorporated

Cambridge, MA (Massachusetts) US

Medicines and Medical Drugs, Veterinary Medicines or Pharmaceuticals...

TEL: +617 444 6100 FAX: +617 444 6680
http://www.vpharm.com

Company location:

News and Blogs

Total : 104 View more »

Vertex Pharmaceuticals Announces Webcast of its Presentations at Two Investor Conferences (Business Wire)

finance.yahoo.com | Oct 30, 2009

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX - News) today announced that it will webcast its presentations at the

http://finance.yahoo.com/news/Vertex-Pharmaceuticals-bw-2790451287.html?x=0&.v=1

Vertex Pharma reinitiated with "neutral"

www.newratings.com | Oct 21, 2009

NEW YORK, October 21 (newratings.com) - Analysts at Wedbush Morgan reinitiate coverage of Vertex Pharma (ticker: VRTX) with a "neutral" rating. The target price is set to $42. [more]

http://www.newratings.com/en/main/company_headline.m?id=1979336

Bend Research signs collaboration agreement with Vertex Pharmaceuticals

www.bioportfolio.co.uk | 1 hour 54 minutes ago

Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory

http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3605503&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3605503&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2321568180%26amp%3bz%3d950242273&THEHOST=site+d.moreover.com

Vertex Pharmaceuticals Reports Third Quarter 2009 Financial Results and Highlights Recent Business and Clinical Progress (Business Wire)

finance.yahoo.com | Oct 26, 2009

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX - News) today reviewed recent

http://finance.yahoo.com/news/Vertex-Pharmaceuticals-bw-4083515107.html?x=0&.v=1

News from Zibb.com

Total : 36 View more »

Vertex Pharmaceuticals Announces Webcast of its Presentations at Two Investor Conferences - Zibb.com

CAMBRIDGE, Mass., Oct 30, 2009 (BUSINESS WIRE) --

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentations at the Oppenheimer 20th Annual Healthcare Conference on Wednesday, November 4, 2009 at 2:10 p.m. EST and at the Credit Suisse 18th Annual Healthcare Conference on Thursday, November 12, 2009 at 7:30 a.m. MST (9:30 a.m. EST).

The presentations will be webcast live and may be accessed from 'Events & Presentations' on the home page of Vertex's website at www.vrtx.com. A replay of the webcasts will also be available on the Company's website for two weeks following each presentation. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.

About Vertex

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.

Lexiva is a registered trademark of the GlaxoSmithKline group of companies.

Vertex's press releases are available at www.vrtx.com.

(VRTX-WEB)

SOURCE: Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated 
Lora Pike, 617-444-6755 
Associate Director, Investor Relations

Companies: Vertex Pharmaceuticals Inc. (VRTX)

Permalink

Vertex Pharmaceuticals Down 4.3% Since SmarTrend's Sell Recommendation - Zibb.com

Oct 29, 2009 (SmarTrend(R) Spotlight via COMTEX) --

SmarTrend, our proprietary pattern recognition system, called a Downtrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on October 05, 2009 at $34.57.

Since then, Vertex Pharmaceuticals has returned 4.3% as of today's recent price of $33.10. Want to profit from these alerts?

Go to www.mysmartrend.com now for a FREE two-week trial.

Write to Chip Brian at cbrian@tradethetrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html

Companies: Vertex Pharmaceuticals Inc. (VRTX)

Permalink

Vertex Pharmaceuticals Incorporated (VRTX) Corporate Event Announcement Notice - Zibb.com

Oct 26, 2009 (Wall Street Horizon via COMTEX) --

Vertex Pharmaceuticals Incorporated (VRTX)

Expected next earnings release:
Announcement date: 10/26/2009 - After Market
Earnings Quarter: Q3
Announcement Status: Verified

Expected next investor conference call information:
Conference Call Date: 10/26/2009
Conference Call Time (ET): 5:00 PM
Conference Call URL: http://investors.vrtx.com/eventdetail.cfm?eventid=73499

Companies: Vertex Pharmaceuticals Inc. (VRTX)

Permalink

Vertex Pharmaceuticals Down 4% Since SmarTrend's Sell Recommendation - Zibb.com

Oct 20, 2009 (SmarTrend(R) Spotlight via COMTEX) --

SmarTrend, our proprietary pattern recognition system, called a Downtrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on October 05, 2009 at $34.58.

Since then, Vertex Pharmaceuticals has returned 4% as of today's recent price of $33.20. Want to profit from these alerts?

Go to www.mysmartrend.com now for a FREE two-week trial.

Write to Chip Brian at cbrian@tradethetrend.com

---------------------------------------------------------------------------------------------

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html

Companies: Vertex Pharmaceuticals Inc. (VRTX)

Permalink

Web Sites

Total : 85 View more »

Copyright © 2009 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.

http://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&Description=&Image=&symb=VRTX&sid=7853

Drug Discovery & Development Job Search

www.dddmag.com

in the discovery, development, manufacturing and... and finish drug product processes for protein parenteral products at contract manufacturing sites, in...

http://www.dddmag.com/JobSearchResultsXML.aspx?pid=8250162790057827&query=drug+discovery+manufacturing&location=&sort=&radius=25&sitetype=&jobtype=all&sr=&limit=10&fromage=any&start=

PharmaVitae 2002: Vertex Pharmaceuticals (market briefing)

This analysis examines the current position and future outlook for Vertex in the emerging biotechnology sector. It encompasses company strategy, comparative portfolio and pipeline analysis and assessment of financial performance, providing 1, 3 and 6 year sales forecasts for key drugs.

http://www.biz-lib.com/ZDM88017.html

SAS | Customer Success: Vertex Pharmaceuticals

For pharmaceutical and biotechnology companies, the development of a new medicine can take more than a decade – a decade of great expense for the developer and of prolonged anxiety for patients in need of new treatments.

http://www.sas.com/success/vertex.html